Guowan Zheng

7PUBLICATIONS
15CO-AUTHORS
Molecular targetsProteomics and intermolecular interactions (excl. medical proteomics)Medical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 28, 2026
Direct coupling and protective activation of DRP1 by the DNA-PKcs inhibitor KU-57788 synergizes with ferroptosis in anaplastic thyroid cancer cells.

|Oct 14, 2025
Chemoproteomic Profiling Reveals that Triiodothyronine Covalently Labels Cellular Proteins.

Qian Zeng, Xiaoqiao Yan, Junyi Li

|Jun 30, 2025
Selection of Aptamers Targeting Different Epitopes of Recombinant Thyroid-Stimulating Hormone Receptor Protein.

Jiajie Xu, Ying Luo, Zhenhao Long

|Aug 13, 2024
Prosapogenin A induces GSDME-dependent pyroptosis of anaplastic thyroid cancer through vacuolar ATPase activation-mediated lysosomal over-acidification.

Yunye Liu, Yawen Guo, Qian Zeng

|Apr 08, 2024
Incorporating Network Pharmacology and Experimental Validation to Identify Bioactive Compounds and Potential Mechanisms of Digitalis in Treating Anaplastic Thyroid Cancer.

Lei Zhu, Ruimin Liang, Yawen Guo

|Feb 09, 2024
Ruxolitinib induces apoptosis and pyroptosis of anaplastic thyroid cancer via the transcriptional inhibition of DRP1-mediated mitochondrial fission.

Ya-Wen Guo, Lei Zhu, Yan-Ting Duan

Pageof 2

Frequent Collaborators

5 joint publications

Minghua Ge

3 joint publications

Yawen Guo

3 joint publications

Yefeng Cai

2 joint publications

Yiqun Hu